3SBio Inc - Company & Market Research Reports

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

  • Report
  • 112 Pages
From
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition - Product Thumbnail Image

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

  • Report
  • 195 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

  • Report
  • 116 Pages
From
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016 - Product Thumbnail Image

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016

  • Report
  • 69 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Renal Anemia - Pipeline Insight, 2018 - Product Thumbnail Image

Renal Anemia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Erythropoietin Drug - Global Market Outlook (2016-2022) - Product Thumbnail Image

Erythropoietin Drug - Global Market Outlook (2016-2022)

  • Report
  • 132 Pages
From
Global Market for Erythropoietin: 2015-2020 - Product Thumbnail Image

Global Market for Erythropoietin: 2015-2020

  • Report
  • 110 Pages
From
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2018 - Product Thumbnail Image

Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2018

  • Report
  • 64 Pages
From
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2018 - Product Thumbnail Image

Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2018

  • Report
  • 62 Pages
From
Erythropoietin Stimulating Agents: Therapeutic Applications and Global Markets - Product Thumbnail Image

Erythropoietin Stimulating Agents: Therapeutic Applications and Global Markets

  • Report
  • 164 Pages
From
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016 - Product Thumbnail Image

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016

  • Report
  • 68 Pages
From
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

  • Report
  • 359 Pages
From
Hyperphosphatemia - Pipeline Insight, 2018 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • Report
  • 43 Pages
From
Global Erythropoietin Drugs Market 2017-2021 - Product Thumbnail Image

Global Erythropoietin Drugs Market 2017-2021

  • Report
  • 70 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • 730 Pages
From
Loading Indicator
adroll